PRDX2 and mantle cell lymphoma: In a univariate Cox regression analysis, we observed an independent prognostic value of PRDX2 gene expression when evaluated alongside two other MCL risk factors, the MCL proliferation signature and the number of copy number alterations (CNA) (Table 1). Interestingly, we analyzed PRDX2 mRNA levels in primary samples of responder’s and no-responder’s patients to chemotherapy in MCL series # 1 and # 2.